eMedicine Specialties > Urology > Stones

Pregnancy and Urolithiasis: Differential Diagnoses & Workup

Author: Robert O Wayment, MD, Resident Physician, Division of Urology, Southern Illinois University School of Medicine
Coauthor(s): Bradley Fields Schwartz, DO, FACS, Professor of Urology, Director, Center for Laparoscopy and Endourology, Department of Surgery, Southern Illinois University School of Medicine
Contributor Information and Disclosures

Updated: Mar 19, 2009

Differential Diagnoses

Abdominal Abscess
Inflammatory Bowel Disease
Abruptio Placentae
Liver Abscess
Aortic Dissection
Lumbar Disc Disease
Appendicitis
Lumbar Spondylosis
Biliary Colic
Pancreatitis, Acute
Cholecystitis
Preterm Labor
Constipation
Pyonephrosis
Diverticulitis
Renal Arteriovenous Malformation
Duodenal Ulcers
Renal Vein Thrombosis
Ectopic Pregnancy
Splenic Abscess
Gastritis, Acute
Splenic Infarct
Gastroenteritis, Viral
Thoracic Aortic Aneurysm
Glomerulonephritis, Acute
Urinary Tract Infection, Females
Ileus
Urinary Tract Obstruction

Other Problems to Be Considered

Spontaneous renal rupture during pregnancy13
Foreign body obstruction
Small-bowel obstruction
Large-bowel obstruction

Workup

Laboratory Studies

  • Urinalysis - To assess for microscopic hematuria
    • The presence of red blood cells may suggest a calculus.
    • Using both dipstick and microscopic analysis can identify microscopic hematuria in 95% of patients with urinary stones.
    • Pyuria, which can result from an inflammatory reaction to a stone or infection, mandates evaluation of a coexisting urinary tract infection. Urinary tract infection is present in approximately 31%.7
    • Urine pH greater than 7 may signal the presence of infected stones (magnesium-ammonium-phosphate) with urea-splitting organisms (eg, Proteus and Klebsiella species).
    • Acidic urine (pH <5) suggests the presence of a uric acid stone.
  • Urine culture - To identify the offending bacteria and determine antibiotic sensitivities
  • Complete blood cell (CBC) count - To determine the presence or absence of systemic infection
  • Renal panel (serum chemistries)
    • Decreased serum bicarbonate and potassium levels suggest an underlying renal tubular acidosis that may result in the formation of calcium phosphate stones. Elevated serum calcium levels might suggest possible primary or secondary hyperparathyroidism. Hyperuricemia suggests possible gouty diathesis and hyperuricosuria, which can increase the risk for both uric acid and calcium stone formation.
    • Elevated serum creatinine levels suggest azotemia due to ureteral obstruction or chronic renal insufficiency. The physiologic increase in GFR during pregnancy dictates that the serum creatinine and BUN levels should be nearly 25% less than levels in the nonpregnant patient.14
  • Metabolic stone prevention studies (ie, 24-hour urine collection)
    • For patients with a sincere interest in reducing their risk of developing additional urinary stones, a 24-hour urine collection for stone prevention analysis is recommended. However, because of the physiologic and electrolytic changes associated with pregnancy, metabolic studies should be postponed until completion of pregnancy. Patients undergoing metabolic analysis studies should be willing to make long-term changes in their diet or lifestyle and take medications and/or supplements to help reduce their risk of new stone formation.
    • The metabolic evaluation should include, as a minimum, a 24-hour urine collection and determination of total volume and sodium, oxalate, citrate, uric acid, calcium, phosphate, and magnesium. Various commercial programs are available from laboratories such as Mission Pharmacal, LabCorp, Litholink, Dianon Systems, Nichols, and UroCor. All of these provide accurate and reliable results from the 24-hour urine collections. The cornerstone of the metabolic evaluation is the stone analysis. All patients should be encouraged to strain urine until the stone passes or repeat imaging is performed.

Imaging Studies

Radiologic diagnosis of urolithiasis in pregnant patients is complicated by the physiologic and hemodynamic changes of pregnancy, such as increased renal blood flow (RBF) and GFR, in addition to the concern for fetal radiation exposure. Delay in diagnosis or inappropriate therapy may risk maternal renal damage, premature labor, spontaneous abortion, pyonephrosis, and/or maternal hypertension. Tailor the diagnostic evaluation and management of the gravid patient to the individual.

The use of ionizing radiation during pregnancy is a complicated and controversial issue. Radiographic studies should be used judiciously and avoided when possible, particularly during the first trimester. The guidelines available from the American College of Obstetricians and Gynecologists (ACOG) state, “concern about possible effects of high-dose ionizing radiation exposure should not prevent medically indicated diagnostic x-ray procedures from being performed on a pregnant woman. During pregnancy, other imaging procedures not associated with ionizing radiation (eg, ultrasonography, MRI) should be considered instead of x-rays when appropriate.” Concerning fetal dosages of radiation, ACOG states that “....less than 5 rads (5000 millirad [mrd]) has not been associated with an increase in fetal abnormalities or pregnancy loss.”15

Srirangam et al (2008) reported average fetal radiation doses for common diagnostic procedures used in the workup of urolithiasis in pregnancy, as follows:16
  • Ultrasonography - None
  • MRI (<1.5 T) - None
  • KUB, 1.4 milligray (mGy) - 140 mrd
  • Intravenous urography, 1.7 mGy - 170 mrd
  • Renal tract CT scanning, 80 mGy - 800 mrd
  • Technetium Tc 99m renal scan (mercaptoacetyltriglycine [MAG-3] or diethylenetriaminepentaacetic acid [DTPA]), 0.2 mGy - 20 mrd 
Renal ultrasonography, with or without Doppler studies, is recommended as the primary imaging modality in pregnant women. In the event that ultrasonography findings are equivocal and clinical symptoms strongly suggest renal calculi, a limited IVP with reduced films and radiation exposure may be performed. If the ultrasonography and limited IVP test findings are unclear, additional tests or procedures may be indicated, depending on the clinical scenario. However, when indicated, many suggest proceeding directly to ureteroscopy for diagnosis and treatment, especially in the first and second trimesters.17,18,19 Radiation exposure in the third trimester is less of a risk to the fetus.
  • Renal ultrasonography
    • Renal ultrasonography is the first-line screening tool for urolithiasis in pregnant patients. Stothers and Lee (1992) found that renal ultrasonography provided a sensitivity of 34% and specificity of 86%,7 yet Parulkar et al (1998) reported 95% and 87%,6 respectively. The sonogram may not actually show the stone.
    • However, false-positive results may occur in the setting of extrarenal pelvis, vesicoureteral reflux, a high urine-flow rate, parapelvic cysts, and crossing vessels within the renal sinus. Up to 35% of patients with documented acute ureteral obstruction may not demonstrate any significant hydronephrosis, which makes standard ultrasonography less useful. Furthermore, differentiating hydronephrosis caused by an obstructing calculus due to physiologic dilation of pregnancy may be difficult.
    • Advantages of renal ultrasonography include avoidance of radiation exposure to the fetus, no pain, avoidance of proallergenic intravenous contrast material, and the ability to examine coexisting abdominal or pelvic disease etiologies.
  • Vaginal ultrasonography: This has been found valuable in revealing stones in the distal ureter that are not visualized with renal ultrasonography. Laing et al (1994) reported that distal ureteral stones were identified in 13 of 13 patients; renal ultrasonography revealed the distal stones in only 15% of the 13 patients. Laing et al also observed that patients tolerated the procedure well.20 Loughlin and Ker (2002) endorse the use of a transrectal ultrasonography probe if a vaginal transducer is unavailable.21
  • Renal ultrasonography with Doppler sonography
    • In contrast to standard renal ultrasonography, ultrasonography with Doppler studies enables recording of waveform tracings of the renal vasculature. Ureteric obstruction increases renal vascular resistance, resulting in a reduction of diastolic blood flow and a rise in renal resistance. Based on waveform tracings, a resistive index (RI) value is calculated (RI = peak systolic velocity - peak diastolic velocity / peak systolic velocity), providing improved sensitivity and specificity for differentiating obstructed from nonobstructed dilated collecting systems. An elevated RI value of greater than 0.70 is specific for ureteral obstruction. Alternatively, a difference in the RI of 0.04 or more between the affected and contralateral kidney also suggests an obstruction in the side with the higher RI value.
    • Shokeir and Abdulmaaboud (1999) also evaluated the change in RI, which showed increased sensitivity (88%) and specificity (98%) in diagnosing ureteral obstruction.22
    • Color Doppler renal sonography is a new addition to sonographic visualization of calculi, with a reported sensitivity of 100% and a specificity of 91% for diagnosing ureteral obstruction. This important study demonstrates the presence of ureteral jets (streams of densely opacified urine) flowing into the bladder (containing dilute nonopacified urine). The absence of these jets may suggest ureteral obstruction, while symmetric jets indicate the absence of obstruction. In addition, color Doppler studies also aid in differentiating iliac vessels from a dilated ureter.
    • Equivocal sonographic results that do not suggest either physiologic hydronephrosis of pregnancy or urolithiasis require further imaging with limited excretory urography.
    • Disadvantages of renal sonography include the following:
      • Suboptimal determination of the level of obstruction
      • Difficulty in showing the ureters and intraureteral calculi
      • Possible difficulty differentiating physiologic hydronephrosis of pregnancy from acute obstructive hydronephrosis
      • Unable (in most cases) to determine the size or shape of the urinary calculi
      • Difficulty visualizing calculi obscured by overlying bony structures, fetal skeleton, or fecal material
      • Operator dependent
    • Disadvantages of renal sonography with color Doppler include the following:
      • Relies on elevated urine output and density differences between urine in the bladder and urine existing within the ureter
      • Degree of asymmetry of the ureteral jets unaltered from reference range because of calculi causing low-grade or no obstruction
      • Operator dependent
    • Normal findings on renal sonography are consistent with the following results:
      • Degree of renal and ureteral dilation consistent with pregnancy
      • RI value of less than 0.70 in both kidneys
      • Symmetric ureteral jets
      • No specific calculus identified
    • The following results indicate a high probability of urolithiasis during pregnancy:
      • Greater degree of dilatation disproportionate to hydronephrosis of pregnancy in collecting system
      • RI value greater than 0.70 in the symptomatic kidney or change in RI greater than 0.6022
      • Dilated ureter extending below the level of the iliac arteries
      • Asymmetry of ureteral jets
      • Identification of calculus
  • Excretory urography
    • Excretory urography remains an important diagnostic modality for stone detection in nonpregnant women, allowing the investigator to accomplish the following:
      • Establish the presence of an obstruction
      • Locate and determine the size of the offending calculus
      • Estimate renal function
      • Identify anatomic abnormalities that may alter the treatment algorithm
      • Detect altered renal physiology secondary to obstruction
    • Intravenous urography (IVU) or IVP consists of initial abdominal radiography of the KUB followed by a second radiograph obtained 20-30 minutes after the intravenous injection of a contrast medium. The initial KUB radiograph exposes the fetus to 0.002 Gy; however, because the standard IVU necessitates 4 or 5 films, the patient may be exposed to a total of 0.004-0.01 Gy. The dose of radiation during IVU has been reported to be safe to the fetus during the second and third trimesters. Limited IVP, however, has been shown to successfully reveal calculi without the high radiation dose of full IVP. Stothers and Lee (1992) recommend a scout film, a 30-second film, and a 20-minute film. They report successful visualization of 16 of 17 stones in pregnant patients who presented with acute renal colic.7

      The arrow in this intravenous pyelogram of a grav...

      The arrow in this intravenous pyelogram of a gravid female indicates a filling defect at the ureterovesical junction. This finding is most likely consistent with a ureteral stone (distal).

      The arrow in this intravenous pyelogram of a grav...

      The arrow in this intravenous pyelogram of a gravid female indicates a filling defect at the ureterovesical junction. This finding is most likely consistent with a ureteral stone (distal).

    • Indications for excretory urography in a pregnant patient may include the following:
      • Sonography results that are equivocal for pregnancy dilatation or urolithiasis
      • Azotemia suggestive of postrenal obstruction
      • Persistent fever or persistent positive finding on urine culture despite 48 hours of parenteral antibiotic treatment
      • Massive hydronephrosis on abdominal ultrasonography
    • Disadvantages of IVU include the following:
      • Risk of intravenous contrast allergy in the mother and fetus
      • Risk of radiation exposure to the mother and fetus
      • Possible ambiguous differentiation between delayed excretion of contrast material from calculus obstruction and pathologic hydronephrosis, especially in the third trimester
      • Small ureteral calculi obscured by enlarged uterus during IVU studies, especially in the third trimester
  • MRI
    • MRI provides high-quality images of the kidneys and urinary tract with obstruction and is used by some as second line to ultrasonography. It visualizes stones poorly and is therefore rarely indicated.
    • MRI does provide a benefit in its ability to reveal non–urinary-tract pathology that may manifest with similar symptoms (ie, ovarian torsion, appendicitis).16
    • Using T2-weighted imaging, MRI urography can be used to differentiate a physiological upper tract dilatation from a pathologic ureterohydronephrosis during pregnancy and to ascertain whether the obstruction is intrinsic or extrinsic.
    • MRI does not use ionizing radiation or iodinated contrast, but its use during the first trimester is not recommended because the effect of MRI on fetal development is not clear.
    • MRI is expensive, uncomfortable for the pregnant patient, and often unavailable, which further limit its use for urolithiasis evaluation. In addition, it cannot demonstrate the actual stone, only the point of obstruction.
  • Nuclear renal scan
    • Nuclear renal scan using technetium Tc 99m DTPA is an excellent study for objectively establishing the differential renal function and the efficiency of drainage of the dilated collecting system (washout times). DTPA is cleared almost exclusively by glomerular filtration. The rate of clearance provides an excellent estimate of GFR. However, nuclear studies do not allow visualization of stones and provide very limited illustration of anatomy. Differing opinions exist on its utility in the diagnosis of urolithiasis in pregnancy.4,14
    • A drainage half-time of 20 minutes or more indicates obstruction, whereas a drainage half-time of 10 minutes or less indicates nonobstruction.
    • Washout or drainage half-times of 10-20 minutes are considered indeterminate.
  • Unenhanced helical CT scanning: This reported to be highly sensitive (96-97%) and specific (96-99%) and has become the criterion standard in the diagnosis of urinary calculi. It is also effective in differentiating calculi from tumors or blood clots. Despite these benefits, this study has traditionally been avoided in pregnant patients. Recently, White et al (2007) reported on the use of low-dose CT scanning in pregnant patients with suspected urinary calculi, with an average radiation dose of only 705.5 mrd. They assert that this offers an acceptable degree of risk, and they advocate its use in the setting of refractory flank pain and inconclusive ultrasonographic results in pregnant patients.23 However, the use of CT scanning or any study that involves radiation should be avoided when possible, and patients should be counseled appropriately.

Procedures

  • Ureteroscopy
    • Ureteroscopy has emerged as a safe and efficient way to treat urolithiasis during pregnancy.17 Ulvik and associates (1995) have used ureteroscopy to successfully treat urolithiasis and consider it as a diagnostic procedure in difficult cases.19 Rigid or flexible ureteroscopes may be used, but Ulvik et al feel that flexible scopes may be better suited in diagnosis during pregnancy.
    • Rittenberg and Bagley reported the use of ureteroscopy for diagnosis with local anesthesia alone in 1988.24 Currently available ureteroscopes are small and may be used with minimal or no anesthesia.17,25 Lemos and coworkers (2002) feel that ureteroscopy used solely for diagnosis may be aggressive but agree that it can be used as a single modality for diagnosis and removal of ureteral calculi in pregnancy.18 Ureteroscopy offers clear-cut diagnosis, with direct visualization, as well as definitive therapy in the same encounter.
  • Retrograde pyelography: This can successfully reveal ureteral stones in cases with ambiguous sonography and IVU results. However, this study is performed only during stent placement because of the invasiveness of the examination, possible introduction of bacteria and risk of sepsis, and the need for radiation, sedation, and cystoscopy. Routine retrograde pyelography is not recommended for documentation of ureteral calculi in pregnant patients.

More on Pregnancy and Urolithiasis

Overview: Pregnancy and Urolithiasis
Differential Diagnoses & Workup: Pregnancy and Urolithiasis
Treatment & Medication: Pregnancy and Urolithiasis
Follow-up: Pregnancy and Urolithiasis
Multimedia: Pregnancy and Urolithiasis
References

References

  1. Folger GK. Pain and pregnancy; treatment of painful states complicating pregnancy, with particular emphasis on urinary calculi. Obstet Gynecol. Apr 1955;5(4):513-8. [Medline].

  2. Rodriguez PN, Klein AS. Management of urolithiasis during pregnancy. Surg Gynecol Obstet. Feb 1988;166(2):103-6. [Medline].

  3. Drago JR, Rohner TJ, Chez RA. Management of urinary calculi in pregnancy. Urology. Dec 1982;20(6):578-81. [Medline].

  4. Biyani CS, Joyce AD. Urolithiasis in pregnancy. II: management. BJU Int. May 2002;89(8):819-23. [Medline].

  5. Swanson SK, Heilman RL, Eversman WG. Urinary tract stones in pregnancy. Surg Clin North Am. Feb 1995;75(1):123-42. [Medline].

  6. Parulkar BG, Hopkins TB, Wollin MR, Howard PJ Jr, Lal A. Renal colic during pregnancy: a case for conservative treatment. J Urol. Feb 1998;159(2):365-8. [Medline].

  7. Stothers L, Lee LM. Renal colic in pregnancy. J Urol. Nov 1992;148(5):1383-7. [Medline].

  8. Denstedt JD, Razvi H. Management of urinary calculi during pregnancy. J Urol. Sep 1992;148(3 Pt 2):1072-4; discussion 1074-5. [Medline].

  9. Glowacki LS, Beecroft ML, Cook RJ, Pahl D, Churchill DN. The natural history of asymptomatic urolithiasis. J Urol. Feb 1992;147(2):319-21. [Medline].

  10. Gregory MC, Mansell MA. Pregnancy and cystinuria. Lancet. Nov 19 1983;2(8360):1158-60. [Medline].

  11. Boridy IC, Maklad N, Sandler CM. Suspected urolithiasis in pregnant women: imaging algorithm and literature review. AJR Am J Roentgenol. Oct 1996;167(4):869-75. [Medline].

  12. Waltzer WC. The urinary tract in pregnancy. J Urol. Mar 1981;125(3):271-6. [Medline].

  13. Wolff JM, Jung PK, Adam G, Jakse G. Non-traumatic rupture of the urinary tract during pregnancy. Br J Urol. Nov 1995;76(5):645-8. [Medline].

  14. Loughlin KR, McAleer SJ. Management of Urological Problems in Pregnancy: A Rationale and Strategy. AUA Update Series. 2005;24: Lesson 5.

  15. American College of Obstetricians and Gynecologists (ACOG). ACOG Committee Opinion. Number 299, September 2004 (replaces No. 158, September 1995). Guidelines for diagnostic imaging during pregnancy. Obstet Gynecol. Sep 2004;104(3):647-51. [Medline].

  16. Srirangam SJ, Hickerton B, Van Cleynenbreugel B. Management of urinary calculi in pregnancy: a review. J Endourol. May 2008;22(5):867-75. [Medline].

  17. Lifshitz DA, Lingeman JE. Ureteroscopy as a first-line intervention for ureteral calculi in pregnancy. J Endourol. Feb 2002;16(1):19-22. [Medline].

  18. Lemos GC, El Hayek OR, Apezzato M. Rigid ureteroscopy for diagnosis and treatment of ureteral calculi during pregnancy. Int Braz J Urol. Jul-Aug 2002;28(4):311-5; discussion 316. [Medline].

  19. Ulvik NM, Bakke A, Høisaeter PA. Ureteroscopy in pregnancy. J Urol. Nov 1995;154(5):1660-3. [Medline].

  20. Laing FC, Benson CB, DiSalvo DN, Brown DL, Frates MC, Loughlin KR. Distal ureteral calculi: detection with vaginal US. Radiology. Aug 1994;192(2):545-8. [Medline].

  21. Loughlin KR, Ker LA. The current management of urolithiasis during pregnancy. Urol Clin North Am. Aug 2002;29(3):701-4. [Medline].

  22. Shokeir AA, Abdulmaaboud M. Resistive index in renal colic: a prospective study. BJU Int. Mar 1999;83(4):378-82. [Medline].

  23. White WM, Zite NB, Gash J, Waters WB, Thompson W, Klein FA. Low-dose computed tomography for the evaluation of flank pain in the pregnant population. J Endourol. Nov 2007;21(11):1255-60. [Medline].

  24. Rittenberg MH, Bagley DH. Ureteroscopic diagnosis and treatment of urinary calculi during pregnancy. Urology. Nov 1988;32(5):427-8. [Medline].

  25. Scarpa RM, De Lisa A, Usai E. Diagnosis and treatment of ureteral calculi during pregnancy with rigid ureteroscopes. J Urol. Mar 1996;155(3):875-7. [Medline].

  26. Houshiar AM, Ercole CJ. Urinary calculi during pregnancy. When are they cause for concern?. Postgrad Med. Oct 1996;100(4):131-8. [Medline].

  27. Barron WM. Medical evaluation of the pregnant patient requiring nonobstetric surgery. Clin Perinatol. Oct 1985;12(3):481-96. [Medline].

  28. Lipkin M, Shah O. The use of alpha-blockers for the treatment of nephrolithiasis. Rev Urol. 2006;8 Suppl 4:S35-42. [Medline].

  29. Parsons JK, Hergan LA, Sakamoto K, Lakin C. Efficacy of alpha-blockers for the treatment of ureteral stones. J Urol. Mar 2007;177(3):983-7; discussion 987. [Medline].

  30. Watterson JD, Girvan AR, Beiko DT, Nott L, Wollin TA, Razvi H. Ureteroscopy and holmium:YAG laser lithotripsy: an emerging definitive management strategy for symptomatic ureteral calculi in pregnancy. Urology. Sep 2002;60(3):383-7. [Medline].

  31. Loughlin KR. Management of urologic problems during pregnancy. Urology. Aug 1994;44(2):159-69. [Medline].

  32. Evans HJ, Wollin TA. The management of urinary calculi in pregnancy. Curr Opin Urol. Jul 2001;11(4):379-84. [Medline].

  33. Kavoussi LR, Jackman SV, Bishoff JT. Re: Renal colic during pregnancy: a case for conservative treatment. J Urol. Sep 1998;160(3 Pt 1):837-8. [Medline].

  34. Kavoussi LR, Albala DM, Basler JW, Apte S, Clayman RV. Percutaneous management of urolithiasis during pregnancy. J Urol. Sep 1992;148(3 Pt 2):1069-71. [Medline].

  35. Akpinar H, Tüfek I, Alici B, Kural AR. Ureteroscopy and holmium laser lithotripsy in pregnancy: stents must be used postoperatively. J Endourol. Feb 2006;20(2):107-10. [Medline].

  36. Streem SB. Contemporary clinical practice of shock wave lithotripsy: a reevaluation of contraindications. J Urol. Apr 1997;157(4):1197-203. [Medline].

  37. Kakkar VV. The current status of low-dose heparin in the prophylaxis of thrombophlebitis and pulmonary embolism. World J Surg. Jan 1978;2(1):3-18. [Medline].

  38. Pisegna JR. Switching between intravenous and oral pantoprazole. J Clin Gastroenterol. Jan 2001;32(1):27-32. [Medline].

  39. Li DK, Liu L, Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ. Aug 16 2003;327(7411):368. [Medline].

  40. Boubred F, Vendemmia M, Garcia-Meric P, Buffat C, Millet V, Simeoni U. Effects of maternally administered drugs on the fetal and neonatal kidney. Drug Saf. 2006;29(5):397-419. [Medline].

  41. Koren G, Florescu A, Costei AM, Boskovic R, Moretti ME. Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis. Ann Pharmacother. May 2006;40(5):824-9. [Medline].

  42. Khoo L, Anson K, Patel U. Success and short-term complication rates of percutaneous nephrostomy during pregnancy. J Vasc Interv Radiol. Dec 2004;15(12):1469-73. [Medline].

  43. Armstrong SJ, Witcombe JB. Calcified hydronephrosis in pregnancy. Br J Radiol. Oct 1991;64(766):966-8. [Medline].

  44. Asgari MA, Safarinejad MR, Hosseini SY. Extracorporeal shock wave lithotripsy of renal calculi during early pregnancy. BJU Int. Oct 1999;84(6):615-7. [Medline].

  45. Butler EL, Cox SM, Eberts EG. Symptomatic nephrolithiasis complicating pregnancy. Obstet Gynecol. Nov 2000;96(5 Pt 1):753-6. [Medline].

  46. Cass AS, Smith CS, Gleich P. Management of urinary calculi in pregnancy. Urology. Nov 1986;28(5):370-2. [Medline].

  47. Fabrizio MD, Gray DS, Feld RI. Placement of ureteral stents in pregnancy using ultrasound guidance. Tech Urol. Fall 1996;2(3):121-5. [Medline].

  48. Fligelstone LJ, Datta SN, Evans C. Problematic renal calculi presenting during pregnancy. Ann R Coll Surg Engl. Mar 1996;78(2):142-5. [Medline].

  49. Gana BM, Taube M. Extracorporeal shock wave lithotripsy of renal calculi during early pregnancy. BJU Int. Feb 2000;85(3):384. [Medline].

  50. Gorton E, Whitfield HN. Renal calculi in pregnancy. Br J Urol. Jul 1997;80 Suppl 1:4-9. [Medline].

  51. Hendricks SK, Ross SO, Krieger JN. An algorithm for diagnosis and therapy of management and complications of urolithiasis during pregnancy. Surg Gynecol Obstet. Jan 1991;172(1):49-54. [Medline].

  52. Horowitz E, Schmidt JD. Renal calculi in pregnancy. Clin Obstet Gynecol. Jun 1985;28(2):324-38. [Medline].

  53. Kroovand RL. Stones in pregnancy and in children. J Urol. Sep 1992;148(3 Pt 2):1076-8. [Medline].

  54. Leslie S. Increasing urinary volume. Personal communication. Used with permission. 2001.

  55. Leslie S. The IRS plan for increasing urinary volume. In: Savitz G, Leslie S, eds. The Kidney Stones Handbook. 2nd ed. Roseville, Calif: Four Geez Press; 1999:141-4.

  56. Powell CR, Stoller ML, Schwartz BF. Impact of body weight on urinary electrolytes in urinary stone formers. Urology. Jun 2000;55(6):825-30. [Medline].

  57. Rosenfeld JA. Renal disease and pregnancy. Am Fam Physician. Apr 1989;39(4):209-12. [Medline].

  58. Savitz G, Leslie S. Water, Water Everywhere. In: Savitz G, Leslie S, eds. The Kidney Stones Handbook. 2nd ed. Roseville, Calif: Four Geez Press; 1999:131-40.

  59. Shokeir AA, Mahran MR, Abdulmaaboud M. Renal colic in pregnant women: role of renal resistive index. Urology. Mar 2000;55(3):344-7. [Medline].

  60. Thompson T, Kelly JD, Keane PF. Problematic renal calculi presenting during pregnancy. Ann R Coll Surg Engl. Jul 1996;78(4):399. [Medline].

  61. Wolf MC, Hollander JB, Salisz JA. A new technique for ureteral stent placement during pregnancy using endoluminal ultrasound. Surg Gynecol Obstet. Dec 1992;175(6):575-6. [Medline].

Further Reading

Keywords

urolithiasis in pregnancy, kidney stones, ureteral stones, bladder stones, urolithiasis, calculi, calculus, urosepsis, urinary tract infection, stone formation, uric acid stone disease, calcium stone disease, cystinuria, uric acid stone formation, calcium oxalate stone formation, calcium phosphate stone formation, crystalluria, struvite stones, renal calculi, nephrolithiasis, hypercalcemia, hypercalciuria, hydroureteronephrosis

Contributor Information and Disclosures

Author

Robert O Wayment, MD, Resident Physician, Division of Urology, Southern Illinois University School of Medicine
Robert O Wayment, MD is a member of the following medical societies: American Medical Association and American Urological Association
Disclosure: Nothing to disclose.

Coauthor(s)

Bradley Fields Schwartz, DO, FACS, Professor of Urology, Director, Center for Laparoscopy and Endourology, Department of Surgery, Southern Illinois University School of Medicine
Bradley Fields Schwartz, DO, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Association of Military Osteopathic Physicians and Surgeons, Endourological Society, Society of Laparoendoscopic Surgeons, and Society of University Urologists
Disclosure: Nothing to disclose.

Medical Editor

Jeffrey B Garris, MD, Chief, Assistant Professor, Department of Obstetrics and Gynecology, Division of Urogynecology and Reconstructive Pelvic Surgery, Tulane University School of Medicine
Jeffrey B Garris, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Institute of Ultrasound in Medicine, American Medical Association, American Urological Association, Association of Professors of Gynecology and Obstetrics, Louisiana State Medical Society, Royal Society of Medicine, and Sigma Xi
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Eleanor Lederer, MD, Consulting Staff, Louisville VA Hospital; Professor of Medicine, Director of Nephrology Training Program, Kidney Disease Program, University of Louisville School of Medicine; Director, Metabolic Stone Clinic
Eleanor Lederer, MD is a member of the following medical societies: American Association for the Advancement of Science, American Federation for Medical Research, American Society for Biochemistry and Molecular Biology, American Society for Bone and Mineral Research, American Society of Nephrology, American Society of Transplantation, International Society of Nephrology, Kentucky Medical Association, National Kidney Foundation, and Phi Beta Kappa
Disclosure: Nothing to disclose.

CME Editor

J Stuart Wolf Jr, MD, FACS, David A Bloom Professor of Urology, Director of Division of Minimally Invasive Urology, Department of Urology, University of Michigan
J Stuart Wolf Jr, MD, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Catholic Medical Association, Endourological Society, Society for Urology and Engineering, Society of Laparoendoscopic Surgeons, Society of University Urologists, and Society of Urologic Oncology
Disclosure: Terumo Corporation Consulting fee Consulting; Omeros Corporation Consulting fee Consulting

Chief Editor

Bradley Fields Schwartz, DO, FACS, Professor of Urology, Director, Center for Laparoscopy and Endourology, Department of Surgery, Southern Illinois University School of Medicine
Bradley Fields Schwartz, DO, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Association of Military Osteopathic Physicians and Surgeons, Endourological Society, Society of Laparoendoscopic Surgeons, and Society of University Urologists
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.